DalsnaFinance

AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion To Rebuild Its Pipeline

Stocks simplywall.st By simplywall.st 23 Jun 2026 13:42 1 min read
AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion To Rebuild Its Pipeline

AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion To Rebuild Its Pipeline  simplywall.st

AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion To Rebuild Its Pipeline simplywall.st

Read the full story on simplywall.st → Opens the original article on news.google.com

Summary aggregated from simplywall.st's public RSS feed. The full reporting belongs to simplywall.st — please read it on their site.